Anthony Prince

Person

Mountain View, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Polymorphic antiviral nucleoside compounds
- Patent number 7,393,839
- Issue date Jul 1, 2008
- Roćhe Palo Alto LLC
- Kondamraj Birudaraj
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclylakylamines as muscarinic receptor antagonists
- Patent number 7,361,648
- Issue date Apr 22, 2008
- Roćhe Palo Alto LLC
- Charles Alois Dvorak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclylalkylamines as muscarinic receptor antagonists
- Patent number 7,094,778
- Issue date Aug 22, 2006
- Syntex (USA) LLC
- Charles Alois Dvorak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anhydrous crystalline 1-[4(S)-azido-2(S),3(R)-dihydroxy-4-(hydroxym...
- Patent number 6,864,244
- Issue date Mar 8, 2005
- Roćhe Palo Alto LLC
- Terrence Joseph Connolly
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclylalkylamines as muscarinic receptor antagonists
- Patent number 6,667,301
- Issue date Dec 23, 2003
- Syntex (USA) LLC
- Charles Alois Dvorak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing 1,3-dioxolane derivatives
- Patent number 5,274,108
- Issue date Dec 28, 1993
- Syntex (U.S.A.) Inc.
- Norman H. Dyson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing 1,3-dioxolane derivatives
- Patent number 5,208,331
- Issue date May 4, 1993
- Syntex (U.S.A.) Inc.
- Norman H. Dyson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6,11-Dihydrodibenzo-[b.e.]-thiepin-11-one-3-carboxaldehyde
- Patent number 4,051,148
- Issue date Sep 27, 1977
- Syntex (U.S.A.) Inc.
- Anthony Prince
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Heterocyclylalkylamines as muscarinic receptor antagonists
- Publication number 20060287293
- Publication date Dec 21, 2006
- Roche Palo Alto LLC.
- Charles Alois Dvorak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Polymorphic antiviral nucleoside compounds
- Publication number 20050130915
- Publication date Jun 16, 2005
- Roche Palo Alto LLC.
- Kondamraj Birudaraj
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for preparing antiviral nucleoside derivatives
- Publication number 20050080252
- Publication date Apr 14, 2005
- Roche Palo Alto LLC.
- Andrew John Briggs
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel anhydrous crystalline 1-[4(S)-azido-2(S),3(R)-dihydroxy-4-(hy...
- Publication number 20040162265
- Publication date Aug 19, 2004
- Roche Palo Alto LLC.
- Terrence Joseph Connolly
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antiviral nucleoside derivatives
- Publication number 20040121969
- Publication date Jun 24, 2004
- Roche Palo Alto LLC.
- Robert Than Hendricks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclylalkylamines as muscarinic receptor antagonists
- Publication number 20040087581
- Publication date May 6, 2004
- Charles Alois Dvorak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heterocyclylalkylamines as muscarinic receptor antagonists
- Publication number 20020004501
- Publication date Jan 10, 2002
- Charles Alois Dvorak
- C07 - ORGANIC CHEMISTRY

Anthony Prince

Person

Patents Grantslast 30 patents

Polymorphic antiviral nucleoside compounds

Heterocyclylakylamines as muscarinic receptor antagonists

Heterocyclylalkylamines as muscarinic receptor antagonists

Anhydrous crystalline 1-[4(S)-azido-2(S),3(R)-dihydroxy-4-(hydroxym...

Heterocyclylalkylamines as muscarinic receptor antagonists

Process for preparing 1,3-dioxolane derivatives

Process for preparing 1,3-dioxolane derivatives

6,11-Dihydrodibenzo-[b.e.]-thiepin-11-one-3-carboxaldehyde

Patents Applicationslast 30 patents

Heterocyclylalkylamines as muscarinic receptor antagonists

Polymorphic antiviral nucleoside compounds

Process for preparing antiviral nucleoside derivatives

Novel anhydrous crystalline 1-[4(S)-azido-2(S),3(R)-dihydroxy-4-(hy...

Antiviral nucleoside derivatives

Heterocyclylalkylamines as muscarinic receptor antagonists

Heterocyclylalkylamines as muscarinic receptor antagonists